Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Eslicarbazepine Acetate on Oral Contraceptive PK
NCT02281448Phase 1Completed
- Sponsor
- BIAL
- Start
- Mar 2005
- Primary completion
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of eslicarbazepine acetate in epilepsy (2 arms), sponsored by BIAL. Primary endpoint: Maximum Observed Plasma BIA 2-194 Concentration. Started Mar 2005; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT02281448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02281448.